Vaxcyte, Inc. (PCVX) director files Form 3 reporting zero holdings
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Vaxcyte, Inc. director Markels John filed an initial Form 3 reporting his beneficial ownership. The report states that he owns no Vaxcyte securities, with total direct holdings of 0 shares following the reported position. No purchases, sales, or derivative or option positions are disclosed.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Markels John
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | No securities owned. | -- | -- | -- |
Holdings After Transaction:
No securities owned. — 0 shares (Direct)
Footnotes (1)
Key Figures
Shares owned after reporting: 0.0000 shares
Reported buy transactions: 0
Reported sell transactions: 0
+1 more
4 metrics
Shares owned after reporting
0.0000 shares
Total direct holdings following the Form 3 entry
Reported buy transactions
0
buyCount in transaction summary
Reported sell transactions
0
sellCount in transaction summary
Holding entries reported
1
holdingEntries in transaction summary
Key Terms
Form 3, beneficial ownership, reporting person, derivative positions
4 terms
Form 3 regulatory
"Markels John filed an initial Form 3 reporting his beneficial ownership"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
beneficial ownership financial
"filed an initial Form 3 reporting his beneficial ownership"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
reporting person regulatory
"The Form 3 identifies the reporting person as a director"
derivative positions financial
"No purchases, sales, or derivative positions are disclosed"
Derivative positions are contracts that derive their value from an underlying asset—such as a stock, bond, currency or commodity—and include instruments like options, futures and swaps. Think of them as bets or insurance tied to an asset’s future price: they let investors amplify returns, hedge risk or take exposure without owning the asset directly, which can meaningfully increase potential gains, losses and volatility in a portfolio.
FAQ
What does the Form 3 filed by Markels John mean for Vaxcyte (PCVX)?
The Form 3 shows that director Markels John reports owning no Vaxcyte shares. It is an initial statement of beneficial ownership, indicating his reported starting position as a director is zero, with no accompanying purchases, sales, or derivative holdings disclosed.
Does the Vaxcyte (PCVX) director Markels John own any company stock?
According to the Form 3, director Markels John owns 0 Vaxcyte shares. The filing lists “No securities owned” and reports total direct holdings of 0.0000 shares following the report, with no other equity or derivative interests shown.
Were any stock transactions reported in this Vaxcyte (PCVX) Form 3?
No transactions were reported; the Form 3 is a holding-only entry. The transaction section simply records that no securities are owned, with buyCount, sellCount, and exerciseCount all at 0, and one holding entry reflecting zero shares.
Does Markels John hold any options or derivatives in Vaxcyte (PCVX)?
The Form 3 shows no derivative positions for Markels John. The derivativeSummary is empty and derivativeTransactionCount is 0, indicating no reported options, warrants, or other derivative securities linked to Vaxcyte common stock.
What role does Markels John have at Vaxcyte (PCVX) in this Form 3?
The Form 3 identifies Markels John as a director of Vaxcyte, Inc. He is not listed as an officer and is not reported as a ten percent owner, and his initial statement reports zero beneficial ownership of company securities.